Is PSA Screening Suitable for Men Seeing a Uro Oncologist in Pune

Seeing a uro-oncologist does not automatically mean you need a PSA test. By considering your age, symptoms, family history, previous results, medicines and overall health, you can decide whether screening is worthwhile and understand what should happen after an abnormal or normal result.

Key takeaways

  • Discuss PSA screening based on age, family history, ethnicity and life expectancy.
  • Treat urinary or prostate symptoms as an investigation, not routine screening.
  • A raised PSA does not confirm prostate cancer.
  • Ask what repeat tests, MRI or biopsy are appropriate after an elevated PSA.

Who should discuss PSA screening, and when should it begin?

Seeing a uro-oncologist does not automatically create an indication for prostate cancer screening for men. Screening is a preventive choice for men without prostate-cancer symptoms, and the decision depends on age, ethnicity, family history, previous PSA results, life expectancy and other illnesses.

Discuss the starting point in these age ranges:

  • Around 50: average-risk men.
  • Around 45: men at higher risk, including Black men or men with a first-degree relative diagnosed young.
  • Around 40: men with more than one first-degree relative diagnosed young.

These ages begin a conversation, not a compulsory blood test. For average-risk men, shared decision-making is most relevant from ages 55 to 69 because PSA testing can lead to false positives, biopsies, overdiagnosis and treatment effects. Routine PSA screening after 70 is not recommended for most men, although individual health and preferences still matter.

A baseline PSA helps set the next interval. Men with a very low PSA and lower risk may test less frequently, while higher PSA or stronger family risk may justify closer review; an automatic annual schedule is not appropriate for everyone. A repeat test should reflect the result and risk profile.

Screening is unlikely to provide useful benefit when limited life expectancy or serious competing illness makes treatment unlikely to improve survival. A consultation prompted by “uro oncologist psa screening for men in pune” should therefore start with whether screening could help you, not with an assumption that specialist attendance makes it necessary.

Is this screening, or do your symptoms require an investigation?

An asymptomatic man choosing PSA screening has no urinary or systemic warning symptoms; he is discussing prevention. A man with weak flow, urgency, frequent urination, retention, blood in urine or semen, bone pain, or unexplained weight loss needs assessment, not a PSA result treated as the entire evaluation.

Causes include benign enlargement, infection, locally advanced cancer and other urinary conditions.

SituationWhat PSA can doWhat you need
Preventive screeningEstimates risk before symptomsDiscuss benefit, false positives and biopsy harms during PSA screening in Pune
Symptoms presentAdds information but cannot explain the problem aloneClinical examination and targeted urinary assessment
Possible infection or obstructionCan be temporarily misleadingTreat or investigate the cause, then repeat PSA when appropriate

Before a PSA test consultation in Pune, tell the clinician about:

  • Ejaculation in the previous few days, cycling or vigorous exercise, which can affect the reading.
  • A recent urinary infection or prostatitis; testing during inflammation can produce a misleading elevation.
  • Urinary catheterisation, cystoscopy or prostate biopsy, including the procedure date.
  • Finasteride or dutasteride. These 5-alpha-reductase inhibitors lower PSA, so the result needs adjusted interpretation.
  • Any unexpected previous PSA result and whether the test was repeated.

Postponing the blood test after infection, inflammation or a prostate procedure, or repeating an unexpected result under suitable conditions, can provide a more useful baseline than acting on a distorted first reading.

What does a PSA number actually tell you?

A single PSA value cannot diagnose prostate cancer. PSA is prostate-specific, not cancer-specific: benign prostatic enlargement, prostatitis, urinary infection and recent prostate or urinary procedures can raise it. Finasteride and dutasteride can lower it, so provide your complete medicine list and recent urinary history.

Finding or measureWhat it examinesWhat it can add
PSA densityPSA in relation to prostate volumeHelps assess whether the PSA is high for the gland’s size
PSA velocityChange in PSA across earlier testsShows whether the result is rising over time
Free-to-total PSA ratioFree PSA compared with total PSAAdds risk information in selected men

Interpretation combines age, prostate size, family history, medicines, examination findings and earlier PSA values. Laboratory reference ranges do not create a Pune-specific biopsy cutoff; the same number can mean different things in different men. During a uro oncologist prostate checkup in Pune, ask what these factors do to your individual risk.

PSA screening in Pune still requires clinical assessment.

A normal result lowers risk but does not eliminate cancer, while an elevated result does not prove it. If a result is unexpected, repeating it under suitable conditions can prevent one misleading reading from driving an immediate biopsy. Persistent concern may lead to examination, MRI or biopsy; only biopsy establishes a tissue diagnosis.

What happens after an elevated PSA?

An elevated PSA is a reason to investigate, not a cancer diagnosis. During prostate cancer screening for men, the clinician may check for urinary infection, prostatitis or benign prostate enlargement, review recent catheterisation, cystoscopy or biopsy, check medicines such as finasteride or dutasteride, repeat the PSA, and perform a digital rectal examination.

If concern remains after these checks, the next steps may include:

  • Use a prostate-cancer risk calculator combining age, family history, examination findings and earlier PSA results.
  • Arrange multiparametric prostate MRI to identify suspicious regions and decide whether biopsy is needed.
  • Target a biopsy at an MRI-visible lesion, or sample the prostate systematically when the overall risk justifies it.
  • Interpret a negative MRI cautiously: it reduces uncertainty but does not eliminate cancer risk in every man.

Only a prostate biopsy establishes a tissue diagnosis. Before agreeing, ask about infection, bleeding and urinary problems, including difficulty passing urine. A biopsy can also find low-risk cancer that is better managed with active surveillance than immediate surgery or radiotherapy.

The decision weighs those harms against finding clinically significant cancer earlier. False-positive results can cause anxiety and repeated tests; overdiagnosis can expose you to treatment effects such as urinary leakage and erectile dysfunction without improving survival.

A uro-oncologist PSA screening for men in Pune should therefore remain a shared decision, not an automatic response to one abnormal result.

How should you prepare for a personalised PSA decision in Pune?

Screening is suitable only when its likely benefit matches your cancer risk, overall health and willingness to accept false positives, biopsy harms and treatment effects. Seeing a specialist does not lower the threshold for testing or make a biopsy necessary.

Prepare for a PSA test consultation in Pune with:

1. Previous PSA reports, including the date of every test and any earlier abnormal result.

2. A complete medicine list, including finasteride or dutasteride, which lower PSA and change its interpretation.

3. Details of recent urinary infection, prostatitis, catheterisation, cystoscopy, prostate biopsy or other urinary procedures.

4. Your family history: identify relatives with prostate cancer and record their age at diagnosis.

5. A clear symptom history. Ask whether you are being screened without symptoms or investigated because of weak flow, urinary urgency, blood, bone pain or weight loss.

During a uro oncologist prostate checkup in Pune, ask whether repeating the PSA under suitable conditions is safer than acting on one result. Ask how prostate size, PSA density, free-to-total PSA, examination findings and multiparametric MRI would change the plan.

Discuss what a biopsy could find, including low-risk cancer managed with active surveillance, and compare its infection, bleeding and urinary risks with radiotherapy or surgery. Ask how each option could affect continence and erections. Dr Ashwin Tamhankar can help structure this discussion, but you can decline or defer testing after weighing the likely benefit.

Related services

PSA Testing & Prostate Cancer Screening

PSA Testing & Prostate Cancer Screening

PSA Testing & Prostate Cancer Screening

View service →

Prostate Cancer Diagnosis and Surgery

Prostate Cancer Diagnosis and Surgery

Prostate Cancer Diagnosis and Surgery

View service →

Frequently asked questions

  • Who should discuss PSA screening, and when should it begin?

    Men should discuss PSA screening according to age, ethnicity, family history, previous PSA results, life expectancy and other illnesses. Seeing a uro-oncologist alone does not create an indication for screening.

  • Is PSA testing screening or an investigation of symptoms?

    PSA screening is for men without prostate-cancer symptoms. Urinary changes, blood in urine or semen, pelvic pain, or other concerning symptoms require clinical investigation rather than a routine screening decision.

  • What does a PSA number actually tell you?

    PSA measures prostate-specific antigen in the blood. An elevated result can have several causes and does not by itself confirm prostate cancer.

  • What happens after an elevated PSA?

    A uro-oncologist reviews the result, symptoms, examination findings, previous PSA values and possible temporary causes before deciding whether to repeat testing or arrange further assessment such as MRI or biopsy.

  • How should you prepare for a personalised PSA decision in Pune?

    Bring your age, family cancer history, previous PSA reports, medication list, urinary symptoms and details of recent urinary procedures or infections to the consultation.

Nov 22nd, 2026 8:30 AM

Keywords